TOI ONCOLOGY INSTITUTE INC (THE)

The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call

The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call

CERRITOS, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its first quarter 2024 financial results after the market close on Tuesday, May 14, 2024, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).

The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-201-689-8562. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 13746255. The replay will be available until Tuesday, May 21, 2024.

Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at .

About The Oncology Institute

Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit .

Investors

Solebury Strategic Communications



EN
23/04/2024

Underlying

TOIONCOLOGY INSTITUTE INC (THE)

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ONCOLOGY INSTITUTE INC (THE)

 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

The Oncology Institute Announces First Quarter 2024 Earnings Release D...

The Oncology Institute Announces First Quarter 2024 Earnings Release Date and Conference Call CERRITOS, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, LLC (“TOI”) (NASDAQ: TOI) one of the largest value-based oncology groups in the United States, today announced that the company will release its first quarter 2024 financial results after the market close on Tuesday, May 14, 2024, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-407-0789 or for international callers, 1-...

April 23, 2024 1 EN
 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

Jordan McInerney Appointed as Chief Development Officer of The Oncolog...

Jordan McInerney Appointed as Chief Development Officer of The Oncology Institute Executive Brings Wealth of Experience in Advancing Value-Based Specialty Care Models CERRITOS, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is pleased to announce the appointment of Jordan McInerney as the new Chief Development Officer (CDO), effective April 1, 2024. In this role, Mr. McInerney will spearhead growth initiatives for The Oncology Institute across diverse markets, including cultivating new partnerships with payors, driving M&A pr...

April 8, 2024 1 EN
 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

The Oncology Institute and Healthly Forge Strategic Alliance to Elevat...

The Oncology Institute and Healthly Forge Strategic Alliance to Elevate Cancer Care Access to Healthly Patients Across Southern California CERRITOS, Calif., April 04, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) and Healthly, a rapidly growing healthcare company with over 180 primary care physicians, support services, and a focus on preventive medicine, have announced a strategic collaboration aimed at extending high-quality cancer care services to patients throughout Southern California. Commencing July 1, 2024, TOI will offer its cancer care ser...

April 4, 2024 1 EN
 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

The Oncology Institute Reports Fourth Quarter and Full Year 2023 Finan...

The Oncology Institute Reports Fourth Quarter and Full Year 2023 Financial Results and Guidance for 2024 CERRITOS, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its fourth quarter and year ended December 31, 2023. Recent Operational Highlights Remediated material weakness in Internal Controls over review of Complex Accounting Transactions.Signed full-risk capitated contract in South Florida, effective Januar...

March 27, 2024 1 EN
 PRESS RELEASE
Free
TOI ONCOLOGY INSTIT...

MaxHealth & The Oncology Institute Expand Value-Based Care Partnership

MaxHealth & The Oncology Institute Expand Value-Based Care Partnership TOI announces clinical and financial accountability for MaxHealth Oncology Care in 5 Florida Counties CERRITOS, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), a leading value-based oncology group, and MaxHealth, an innovative leader in value-based primary care, have announced a comprehensive new agreement. Under this full-risk arrangement, TOI will assume clinical and financial responsibility for all oncology care provided to patients in Pinellas, Hillsborough, Polk, Broward, a...

March 14, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch